|
⚲
|
| Keyboard |
| Canale-Theakston Carin
✚
|
|
|---|---|
| CIK # | 0001841613 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001841613] | |
| 4 | [0001841613] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| K2 Therapeutics Inc | |
| Canale-Theakston Carin |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 1,750 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 11,100 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 16,000 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 2,125 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 2,125 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 1,400 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 875 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2025-06-18 | Grant | 11,100 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2024-12-17 | Grant | 16,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2024-07-18 | Grant | 2,125 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2023-06-22 | Grant | 42,500 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2022-06-22 | Grant | 28,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2021-06-23 | Grant | 17,500 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2021-01-22 | Grant | 35,000 | $0.00 |